BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7597761)

  • 1. Pharmacokinetics of amikacin, netilmicin and tobramycin in children with chronic renal failure.
    Nayir A; Sirin A; Emre S; Eti S; Yeşilbek T
    Turk J Pediatr; 1995; 37(2):111-6. PubMed ID: 7597761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of netilmicin in renal insufficiency and hemodialysis.
    Herrero A; Rius Alarcó F; García Díez JM; Mahiques E; Domingo JV
    Int J Clin Pharmacol Ther Toxicol; 1988 Feb; 26(2):84-7. PubMed ID: 3045024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Control of serum levels of tobramycin and amikacin during clinical routine treatment conditions (author's transl)].
    Stark GB; Eiermann T; Langmaack H; Daschner F
    Dtsch Med Wochenschr; 1982 Aug; 107(31-32):1182-4. PubMed ID: 7105995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of concomitant administration of piperacillin on the dispositions of netilmicin and tobramycin in patients with end-stage renal disease.
    Halstenson CE; Hirata CA; Heim-Duthoy KL; Abraham PA; Matzke GR
    Antimicrob Agents Chemother; 1990 Jan; 34(1):128-33. PubMed ID: 2327747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pharmacokinetics of the new aminoglycoside antibiotics: tobramycin, lividomycin, amikacin, sisomicin in the patient with normal renal function and in renal insufficiency. Dosage rules].
    Oksenhendler G; Leroy A; Humbert G; Fillastre JP; Winckler C
    Anesth Analg (Paris); 1977; 34(1):93-110. PubMed ID: 587022
    [No Abstract]   [Full Text] [Related]  

  • 6. Aminoglycoside redistribution phenomenon after hemodialysis: netilmicin and tobramycin.
    Halstenson CE; Berkseth RO; Mann HJ; Matzke GR
    Int J Clin Pharmacol Ther Toxicol; 1987 Jan; 25(1):50-5. PubMed ID: 3557729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.
    Halacova M; Kotaska K; Kukacka J; Vavrova V; Kuzelova M; Ticha J; Prusa R
    J Clin Pharm Ther; 2008 Aug; 33(4):409-17. PubMed ID: 18613859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum cystatin C for the prediction of glomerular filtration rate with regard to the dose adjustment of amikacin, gentamicin, tobramycin, and vancomycin.
    Hermida J; Tutor JC
    Ther Drug Monit; 2006 Jun; 28(3):326-31. PubMed ID: 16778715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The nephrotoxic potential of netilmicin as determined in a rat model.
    Luft FC
    Scand J Infect Dis Suppl; 1980; Suppl 23():82-90. PubMed ID: 6937971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Netilmicin treatment of complicated urinary tract infections.
    Madsen PO; Baumueller A; Frimodt-Møller N; Hoyme U; Lau C; Maigaard S; Nielsen OS; Welling PG
    Scand J Infect Dis Suppl; 1980; Suppl 23():128-31. PubMed ID: 6937956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of netilmicin and other aminoglycosides on renal function. A survey of the literature on the nephrotoxicity of netilmicin.
    Dahlager JI
    Scand J Infect Dis Suppl; 1980; Suppl 23():96-102. PubMed ID: 7010549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional, histological, biochemical renal modifications. Comparative study of dibekacin, gentamicin, tobramycin, netilmicin and amikacin].
    Viotte G; Olier B; Morin JP; Godin M
    Nouv Presse Med; 1982 Nov; 11(46):3419-25. PubMed ID: 7155850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside monitoring: perspective on current trends in the Western Cape.
    van der Bijl P
    S Afr Med J; 2005 Jul; 95(7):474-7. PubMed ID: 16156442
    [No Abstract]   [Full Text] [Related]  

  • 14. Netilmicin use in pediatric patients.
    Chindasilpa V; Schauf V; Hamilton LR; Riff LJ
    Dev Pharmacol Ther; 1980; 1(4):238-53. PubMed ID: 7438970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carbenicillin inactivation of aminoglycosides in patients with severe renal failure.
    Weibert R; Keane W; Shapiro F
    Trans Am Soc Artif Intern Organs; 1976; 22():439-43. PubMed ID: 951863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of type of dialyzer on the pharmacokinetics of amikacin.
    Lanao JM; Dominguez-Gil A; Tabernero JM; Macias JF
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):197-202. PubMed ID: 6862725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in man.
    De Broe ME; Verbist L; Verpooten GA
    J Antimicrob Chemother; 1991 May; 27 Suppl C():41-7. PubMed ID: 1856145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gentamicin, tobramycin and netilmicin pharmacokinetics in plasma and pleural fluid.
    Limthongkul S; Poshyachinda M; Charoenlap P; Nuchprayoon C
    J Med Assoc Thai; 1988 Oct; 71(10):541-7. PubMed ID: 3249161
    [No Abstract]   [Full Text] [Related]  

  • 19. Aminoglycosides in intermittent hemodialysis: pharmacokinetics with individual dosing.
    Dager WE; King JH
    Ann Pharmacother; 2006 Jan; 40(1):9-14. PubMed ID: 16332944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of netilmicin during hemodialysis: comparison of four artificial kidneys.
    Herrero A; Rius Alarcó F; García-Díez JM; Mahiques E; Domingo JV
    Int J Clin Pharmacol Ther Toxicol; 1988 Dec; 26(12):605-9. PubMed ID: 3209278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.